Form 4: Artivion SVP, Clinical & MD Affairs, Marshall S. Stanton, Sells Shares to Cover Tax Obligations

Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., sold 2,183 shares of common stock on March 20, 2024, to cover tax withholding obligations.

Summary

• On March 20, 2024, Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc. (AORT), sold 2,183 shares of common stock.
• The shares were sold at a price of $20.39 per share.
• The sale was executed to cover tax withholding obligations arising from the vesting of restricted stock awards.
• Following the transaction, Stanton beneficially owns 83,296 shares of Artivion, Inc.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock sale for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.

Stakeholder Impact

• The sale of shares by an officer could be perceived neutrally by shareholders as it is related to tax obligations.

Key Dates